paroxetine has been researched along with Rhabdomyolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, W; Jiang, D; Liang, H; Lin, Q; Lin, Y; Wang, Y | 1 |
| Gómez-Grande, ML; Martín-Rodríguez, C; Ortega-Carnicer, J; Portilla-Botelho, M | 1 |
2 other study(ies) available for paroxetine and Rhabdomyolysis
| Article | Year |
|---|---|
Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database.
Topics: Adverse Drug Reaction Reporting Systems; Bayes Theorem; Fluvoxamine; Humans; Paroxetine; Pharmacovigilance; Rhabdomyolysis; Selective Serotonin Reuptake Inhibitors; United States; United States Food and Drug Administration | 2023 |
[Paroxetine-induced severe hyponatremic rhabdomyolisis].
Topics: Cations; Coma; Depressive Disorder; Diagnosis, Differential; Epilepsy, Tonic-Clonic; Female; Humans; Hyponatremia; Lorazepam; Middle Aged; Muscle Cells; Paroxetine; Rhabdomyolysis; Saline Solution, Hypertonic; Selective Serotonin Reuptake Inhibitors | 2008 |